JOINT Corp (JYNT) Form 10-Q — Aug 6, 2026
The Joint Corp. reported Q2 2026 franchise revenue of $15.2 million, up 14.4% year over year, with net income of $653,021 versus $93,363 a year earlier. Six-month revenue rose 13.9% to $30.0 million and diluted EPS doubled to $0.14 from $0.07, aided by continued expansion of the franchise base and a new national marketing fund contribution. Underlying demand metrics weakened, however: comp sales fell 2.8%, system-wide sales declined 3.7% to $128.0 million, and franchise license sales slipped to 10 from 13.
Key figures
- Eps
- 0.05
- Revenue
- 15181914
- Net Income
- 653021
- Total Debt
- 0
- Revenue Yoy
- 14.4%
- Total Assets
- 51627349
- Cash Position
- 22157203
- Shares Outstanding
- 14143154
- Total clinics
- 941
- H1 buyback usd
- 1800000
- Six month revenue
- 30002147
- Franchised clinics
- 896
- H1 buyback avg price
- 8.31
- Six month net income
- 1952156
- System wide sales q2
- 128000000
- Vigeo purchase price
- 400000
- Six month diluted eps
- 0.14
- Addisco purchase price
- 1500000
- Credit facility maturity
- August 31, 2029
- Six month revenue yoy pct
- 13.9
- Elite chiro purchase price
- 2300000
- Franchise licenses sold q2 2025
- 13
- Franchise licenses sold q2 2026
- 10
- Remaining buyback authorization
- 3800000
- Company owned or managed clinics
- 45
- Adjusted ebitda q2 net operations
- 3160153
Price after filing
Close on the filing date to close N calendar days later (from $8.28). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.